Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.31 |
| ▸ | RELA | Q04206 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toliodium SCHEMBL1155683 | 0.93 | ACHE (0.37) | ACHETDP1 | |
| Toliodium SCHEMBL29810005 | 0.90 | ACHE (0.32) | ACHELMNATSHRALOX12 | |
| SCHEMBL132586 | 0.89 | — | — | |
| Hydrogen Sulfide SCHEMBL30375675 | 0.87 | — | — | |
| SCHEMBL21679593 | 0.83 | — | — | |
| Toluene SCHEMBL27946707 | 0.82 | ACHE (0.52) | ACHELMNATSHRALOX12SMN1; SMN2 | |
| SCHEMBL133838 | 0.81 | SCN5A (0.31) | ACHE | |
| SCHEMBL3753882 | 0.81 | TSHR (0.48) | ACHELMNATSHRNPC1RAB9A | |
| SCHEMBL2579597 | 0.81 | CA4 (0.41) | LMNATDP1NPC1RAB9ARELA | |
| SCHEMBL1001143 | 0.81 | CA4 (0.41) | LMNATDP1NPC1RAB9ARELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100039684-A1 | SENSITIZER DYES FOR PHOTOACID GENERATING SYSTEMS USING SHORT VISIBLE WAVELENGTHS | FORCETEC CO., LTD. (KR) | 2010-02-18 | — | — | US | claimed |
| EP-2054770-A2 | SENSITIZER DYES FOR PHOTOACID GENERATING SYSTEMS USING SHORT VISIBLE WAVELENGTHS | STX Aprilis, Inc. (US) | 2009-05-06 | — | — | EP | claimed |
| WO-2008021208-A2 | SENSITIZER DYES FOR PHOTOACID GENERATING SYSTEMS USING SHORT VISIBLE WAVELENGTHS | STX APRILIS, INC. (US) | 2008-02-21 | — | — | WO | claimed |
| EP-1578870-A2 | SENSITIZER DYES FOR PHOTOACID GENERATING SYSTEMS | Aprilis, Inc. (US) | 2005-09-28 | — | — | EP | claimed |
| WO-2004059389-A2 | SENSITIZER DYES FOR PHOTOACID GENERATING SYSTEMS | APRILIS, INC. (US) | 2004-07-15 | — | — | WO | claimed |
| EP-3288997-B1 | ADHESIVE COMPOSITIONS | POWDERTECH BICESTER LTD (GB) | 2020-12-30 | — | — | EP | disclosed |
| US-10689547-B2 | Adhesive compositions | POWDERTECH (BICESTER) LIMITED (GB) | 2020-06-23 | — | — | US | disclosed |
| US-20180355214-A1 | ADHESIVE COMPOSITIONS | POWDERTECH (BICESTER) LIMITED (GB) | 2018-12-13 | — | — | US | disclosed |
| EP-3288997-A1 | ADHESIVE COMPOSITIONS | Powdertech (Bicester) Limited (GB) | 2018-03-07 | — | — | EP | disclosed |
| WO-2016174469-A1 | ADHESIVE COMPOSITIONS | POWDERTECH (BICESTER) LIMITED (GB) | 2016-11-03 | — | — | WO | disclosed |
| US-20130075670-A1 | AMINOBENZENE COMPOSITIONS AND RELATED DEVICES AND METHODS | PLEXTRONICS, INC. (US) | 2013-03-28 | — | — | US | disclosed |
| US-8283002-B2 | Aminobenzene compositions and related devices and methods | PLEXTRONICS, INC. (US) | 2012-10-09 | — | — | US | disclosed |
| US-20060019197-A1 | Sensitizer dyes for photoacid generating systems | APRILIS, INC. (US) | 2006-01-26 | — | — | US | disclosed |
| EP-1591097-A1 | Cationically curing two component materials containing a noble metal catalyst | 3M Espe AG (DE) | 2005-11-02 | — | — | EP | disclosed |
| EP-1578870-A2 | SENSITIZER DYES FOR PHOTOACID GENERATING SYSTEMS | Aprilis, Inc. (US) | 2005-09-28 | — | — | EP | disclosed |
| US-20040249181-A1 | Holographic storage medium comprising polyfunctional epoxy monomers capable of undergoing cationic polymerization | APRILIS, INC. | 2004-12-09 | — | — | US | disclosed |
| US-6784300-B2 | MONOMER/OLIGOMER LINKED BY SILOXANE TO A SILICON ATOM, BINDERS, AN ACID GERNERATOR WHEN EXPOSED TO ACTINIC RADIATION AND A SENSITIZER | APRILIS, INC. | 2004-08-31 | — | — | US | disclosed |
| WO-2004059389-A2 | SENSITIZER DYES FOR PHOTOACID GENERATING SYSTEMS | APRILIS, INC. (US) | 2004-07-15 | — | — | WO | disclosed |
| US-6613437-B1 | Two-component preparations comprising components (I) and (II), wherein at least one component comprises epoxy compounds and the preparations cure by cationic polymerization, initiated by Lewis and/or Bronsted acids, after mixing of the two | 3M ESPE AG (DE) | 2003-09-02 | — | — | US | disclosed |
| US-20020068223-A1 | Holographic storage medium comprising polyfunctional epoxy monomers capable of undergoing cationic polymerization | APRILIS, INC. | 2002-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130075670-A1 | AMINOBENZENE COMPOSITIONS AND RELATED DEVICES AND METHODS | HLA-B, AAAS, SLCO2B1 | ACHE 1023/4885LMNA 3728/4885TSHR 4376/4885 |
| US-20020068223-A1 | Holographic storage medium comprising polyfunctional epoxy monomers capable of undergoing cationic polymerization | NEFM, EMD, PCNA | ACHE 3802/4885LMNA 571/4885TSHR 4772/4885 |
| US-20040249181-A1 | Holographic storage medium comprising polyfunctional epoxy monomers capable of undergoing cationic polymerization | NEFM, EMD, PCNA | ACHE 3802/4885LMNA 571/4885TSHR 4772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.